Clinical Trial Update: Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating ER-100 for safety in patients with open-angle glaucoma or non-arteritic anterior ischemic optic neuropathy (NAION), c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-arteritic Anterior Ischemic Optic Neuropathy
• Open-angle Glaucoma

Drugs mentioned

• ER-100

Snippet

Sponsor: Life Biosciences Inc. | Conditions: Open Angle Glaucoma (OAG), NAION( Non-arteritic Anterior Ischemic Optic Neuropathy) | Phase 1 | Status: RECRUITING